Vermont lawmakers held a hearing in a committee on Thursday, where they discussed legislation to legalize the psychedelic and to take the first steps towards providing regulated access.
The House Judiciary Committee heard H. 371, a bill introduced by Reps. Chip Troiano and Brian Cina. Chip Troiano said that he personally benefited from using psychedelics.
The panel chairman stated that there was not enough time to pass the proposal out before the lawmakers adjourned in the next few days.
The plan is to quickly bring it up again and move forward with the reforms at the start of next year.
Cina stated, “I’ve been advocating decriminalizing nature for years. I want the government to stop standing in the way of people who are entitled to use plant and fungus medicines for spiritual, religious, or entheogenic uses. “This is a continuation of my work.”
The lawmaker stated that “many cultures use psilocybin in religious ceremonies around the world.” In his own experience, he said, he had been able benefit from healing by using plant and fungus medicines in different ceremonies.
As proposed, the law would remove the fungus from the list of state-prohibited drugs, effectively legalizing it.
The report also calls for the creation of a Psychedelic Treatment Advisory Working group that will be responsible for “examining the use of psychedelics in order to improve mental and physical health, and making recommendations on the establishment of a state program”, similar to those being implemented in Oregon or Colorado.
The eight-member group will be made up of legislators, researchers, advocates, and state officials.
Members will need to review the “latest research and evidence on the benefits and risks associated with clinical psychedelic-assisted treatment” as well as “laws and programmes of other states who have authorized the use psychedelics.”
The bill states that by November 15, 2024, the group must submit a “report with its findings and any legislative recommendations” On Thursday, legislators acknowledged that this provision would need to be delayed if not passed during the current session.
“We know that the psilocybin does not have addictive properties.” Troiano told the hearing on Thursday that psilocybin is not a drug to be used daily. It’s not a daily use drug,” Troiano said at Thursday’s a href=”https://legislature.vermont.gov/committee/document/2024/18/Bill/459868#documents-section” rel=”noopener” target=”_blank”>hearing/a>.
The chairman stated that he expected the legislation to “travel around” the House in different committees and “hopefully, we’ll reach the Senate.”
He said that the Senate had an identical bill, referring to a companion law by Sen. Martine Guilick (D). I believe that we can reach some good conclusions between the two houses.
Vermont legislators have proposed a number of drug policy reforms during this session. These include measures to promote harm-reduction services, decriminalize all drugs, and investigate psychedelics.
Troiano said he became motivated to pursue reforms after hearing about the clinical trials that involved psilocybin in the U.S. Department of Veterans Affairs.
“When I saw the VA was willingly looking into this as a therapy mode, I thought that this is another tool that we can use in order to assist veterans who return from war and suffer post-traumatic stresses,” he stated.
Gov. Phil Scott (R), if the legislation on psilocybin is passed next year, might take a different approach to the issue. He reluctantly approved marijuana legislation in 2018 but vetoed last year a measure that would have established a taskforce to investigate the establishment of safe drug consumption sites.
Marijuana Moment tracks more than 1,000 cannabis and psychedelics bills, as well as drug policy legislation in state legislatures this year. Patreon supporters who pledge at least $25/month gain access to our interactive charts, maps and hearing calendar.
Discover more about our marijuana bills tracker. Become a Patreon supporter to gain access.
—
Vermont is among a growing list of states that have shown interest in reforming psychedelics.
A California bill to legalize possession of certain psychoactive substances and facilitate their use is headed to the Senate Floor under an accelerated process which allows it to bypass further committee consideration.
The Minnesota House passed a health omnibus bill recently that includes provisions for the creation of a psychedelics Task Force to prepare Minnesota for a possible legalization.
A bipartisan group and a Republican North Carolina legislator filed a bill last month to create a grant program of $5 million to support research on the potential therapeutic benefits of psilocybin, and to create a Breakthrough Therapies Research Advisory Board.
After receiving final approval from the Senate, a Washington State bill that promotes research into psilocybin as well as creates a pilot program for therapeutic access to psychedelics in mental health treatment will be heading to Governor’s Desk.
Last month, a Nevada Senate Committee approved a revised version of a bill that would establish a new group to study psychedelics as well as develop a plan for regulated access to therapeutic purposes.
Last month, the Hawaii Senate passed a bill to create a council that would examine possible regulations to allow access to federal “breakthrough therapy” such as psilocybin or MDMA.
Oregon regulators have approved a license for the first psilocybin services center in the country. People will be able use the psychedelic under a controlled and facilitated setting.
Nora Volkow, Director of the National Institute on Drug Abuse, told Senators on Thursday there are emerging signs that psychoedelics have “significant potential” to be used as therapeutic treatments in certain mental health conditions. This is a subject that “greatly interests” researchers.
Based on statistical modelling of policy trends, an analysis published last year in the American Medical Association journal concluded that most states will legalize psychedelics before 2037.
A national survey published in March revealed that a majority of U.S. citizens support the legalization of psychedelic therapy, and are also in favor decriminalizing substances such as psilocybin or MDMA.
Oregon Approves Nation’s First Psilocybin Service Center for Adults To Receive Psychoedelic Treatment
Photo by Dick Culbert.
The original post Vermont Lawmakers Discuss plans to pass psilocybin legalization and psychedelics work group bill next year first appeared on Marijuana Moment.
